Inari Medical Inc. (NARI)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Investors in Inari Medical, Inc. Should Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your Rights - NARI
NEW YORK, NY / ACCESSWIRE / May 31, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
INVESTIGATION PROGRESS ALERT: The Schall Law Firm Encourages Investors in Inari Medical, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 24, 2022 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 12, 2024.
Inari Medical, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your Rights - NARI
NEW YORK, NY / ACCESSWIRE / May 31, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Inari Medical, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your Rights - NARI
NEW YORK, NY / ACCESSWIRE / May 31, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Inari Medical, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 24, 2022 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 12, 2024.
Shareholders of Inari Medical, Inc. Should Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your Rights - NARI
NEW YORK, NY / ACCESSWIRE / May 30, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NARI LAWSUIT ALERT: Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / May 30, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
INARI MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inari Medical, Inc. - NARI
NEW ORLEANS, LA / ACCESSWIRE / May 30, 2024 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 12, 2024 to file lead plaintiff applications in a securities class action lawsuit against Inari Medical, Inc. (NasdaqGS:NARI), if they purchased the Company's shares between February 24, 2022 and February 28, 2024, inclusive (the "Class Period").
Shareholders that lost money on Inari Medical, Inc. (NARI) should contact Levi & Korsinsky about pending Class Action - NARI
NEW YORK, NY / ACCESSWIRE / May 30, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Kessler Topaz Meltzer & Check, LLP Reminds Inari Medical, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit (NARI)
RADNOR, PA / ACCESSWIRE / May 30, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Inari Medical, Inc. ("Inari Medical") (NASDAQ:NARI) on behalf of investors who purchased or acquired Inari Medical common stock between February 24, 2022 through February 28, 2024, inclusive (the "Class Period"). The action charges Inari Medical with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects.
NARI LAWSUIT ALERT: Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / May 30, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Inari Medical Faces Lengthy DOJ Probe and Investor Suit Over Potential Kickbacks to Doctors - Hagens Berman
Hagens Berman Encourages NARI Investors with Substantial Losses to Contact Firm SAN FRANCISCO, CA / ACCESSWIRE / May 30, 2024 / Hagens Berman urges Inari Medical, Inc. (NASDAQ:NARI) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 24, 2022 - Feb. 28, 2024 Lead Plaintiff Deadline: July 12, 2024 Visit: www.hbsslaw.com/investor-fraud/nari Contact the Firm Now: [email protected] 844-916-0895 Inari Medical, Inc. (NARI) Class Action: Inari Medical, a medical device manufacturer, is bracing for a protracted investigation by the Department of Justice (DOJ) centering on allegations of illegal kickbacks to healthcare professionals.
